EUROPEAN JOURNAL OF
PHARMACEUTICAL AND MEDICAL RESEARCH

( An ISO 9001:2015 Certified International Journal )

An International Peer Reviewed Journal for Pharmaceutical, Medical & Biological Sciences

An Official Publication of Society for Advance Healthcare Research (Reg. No. : 01/01/01/31674/16)

European Journal of Pharmaceutical and Medical Research (EJPMR) has indexed with various reputed international bodies like : Google Scholar , Indian Science Publications , InfoBase Index (In Process) , SOCOLAR, China , Research Bible, Fuchu, Tokyo. JAPAN , International Society for Research activity (ISRA) , Scientific Indexing Services (SIS) , Polish Scholarly Bibliography , Global Impact Factor (GIF) (Under Process) , Universal Impact Factor , International Scientific Indexing (ISI), UAE , Index Copernicus , CAS (A Division of American Chemical Society) USA (Under Process) , Directory of Open Access Journal (DOAJ, Sweden, in process) , UDLedge Science Citation Index , CiteFactor , Directory Of Research Journal Indexing (DRJI) , Indian citation Index (ICI) , Journal Index (JI, Under Process) , Directory of abstract indexing for Journals (DAIJ) , Open Access Journals (Under Process) , Impact Factor Services For International Journals (IFSIJ) , Cosmos Impact Factor , Jour Informatics (Under Process) , Eurasian Scientific Journal Index (ESJI) , International Innovative Journal Impact Factor (IIJIF) , Science Library Index, Dubai, United Arab Emirates , Pubmed Database [NLM ID: 101669306] (Under Process) , IP Indexing (IP Value 2.40) , Web of Science Group (Under Process) , Directory of Research Journals Indexing , Scholar Article Journal Index (SAJI) , International Scientific Indexing ( ISI ) , Scope Database ,

ISSN 2394-3211

Impact Factor: 6.222

ICV - 79.57

Abstract

A REVIEW ON MULTIPLE SCLEROSIS AND PERSISTENT HICCUPS MANAGEMENT

Tony M. Kuriakose* and Dr. Arun Raj R.

ABSTRACT

Multiple sclerosis (MS) is a Central Nervous System (CNS) demyelinating disease. The pathological hallmark is the presence of plaques. The paroxysmal symptoms of MS can be managed by gabapentine and carbamazepine. Disease modifying drugs can be employed to decrease the frequency of relapses. The hiccups of long term nature (longer than 48 hours) are termed as persistent hiccups. It’s mainly caused due to the irritation or damage of vagus or phrenic nerve. Gabapentine agonist baclofen and anti-psychotic drug chlorpromazine are the primary choices of treatment for the management of persistent hiccups. The aim of this review is to discuss the Etiopathogenesis, clinical features and all newer treatment strategies for the rational management of multiple sclerosis and persistent hiccups.

Keywords: Multiple sclerosis, Persistent hiccups, Demyelinating disease, Gastroesophageal reflux disease.

[Full Text Article]

SJIF Impact Factor: 6.222

INDEXING

Indexing

LOGIN

NEWS & UPDATION

New Issue Published
Its Our pleasure to inform you that, EJPMR 1 September 2023 Issue has been Published, Kindly check it on https://www.ejpmr.com/issue

EJPMR: SEPTEMBER ISSUE PUBLISHED
SEPTEMBER issue has been successfully launched on 1 SEPTEMBER 2023.

EJPMR New Impact Factor
Its our Pleasure to Inform you that EJPMR Impact Factor has been increased from 5.804 to 6.222, due to high quality Publication at International Level